跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,574 条关于
“VLX-ADC-001”
全部
17,574
临床试验
7,671
药物
6,903
机构
87
资讯
2,913
6个月前
Vienna's VALANX Biotech Secures €3 Million to Advance Precision ADC Platform for Triple-Negative Breast Cancer
9个月前
Cadrenal Therapeutics Acquires First-in-Class 12-LOX Inhibitor VLX-1005 for Heparin-Induced Thrombocytopenia Treatment
3个月前
InduPro Doses First Patient in Phase 1 Trial of Proximity-Based Bispecific ADC IDP-001, Closes $77M Series B
2年前
TORL BioTherapeutics Secures $158 Million to Advance ADC Oncology Pipeline
5年前
STRO-001 Shows Promise in Relapsed/Refractory B-Cell NHL
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
9个月前
Kelun-Biotech and Crescent Biopharma Form Strategic Partnership to Advance Novel Oncology Therapeutics
去年
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder
9个月前
Akari Therapeutics Initiates GMP Manufacturing for Novel ADC AKTX-101 with WuXi XDC Partnership
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
第 1 页,共 292 页
上一页
下一页